Lument Finance Trust, Inc. (LFT) stock: key figures, P/E, revenue and dividend
Real Estate · United States · ISIN US55025L1089
Lument Finance Trust, Inc. financials
| Fiscal year | 2025 |
|---|---|
| EBIT | -2.74 m USD |
| Net income | -2.75 m USD |
| Diluted EPS – continuing operations | -0.14 USD |
Full history since 2012, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Lument Finance Trust, Inc.
Lument Finance Trust, Inc., a real estate investment trust, focuses on investing in, originating, financing, and managing a portfolio of commercial real estate (CRE) debt investments in the United States. It primarily invests in transitional floating rate CRE mortgage loans on middle market multi-family assets and other CRE-related investments, including mezzanine loans, preferred equity, commercial mortgage-backed securities, fixed rate loans, construction loans, and other CRE debt instruments. The company is qualified as a real estate investment trust under the Internal Revenue Code of 1986. As a REIT, it would not be subject to federal income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was formerly known as Hunt Companies Finance Trust, Inc. and changed its name to Lument Finance Trust, Inc. in December 2020. Lument Finance Trust, Inc. was incorporated in 2012 and is headquartered in New York, New York.
More stocks
- IGC Pharma, Inc. (IGC)
- BetterLife Pharma Inc. (BETRF)
- Celularity Inc (CELU)
- AWARE INC /MA/ (AWRE)
- HEALTHY EXTRACTS INC. (HYEX)
- Presurance Holdings, Inc. (PRHI)
- BuzzFeed, Inc. (BZFD)
- Western Uranium & Vanadium Corp. (WSTRF)
- Eva Live Inc (GOAI)
- Crisp Momentum Inc. (CRSF)
- Karbon-X Corp. (KARX)
- ATOSSA THERAPEUTICS, INC. (ATOS)
Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.